Prehabilitation for Colorectal Cancer Patients With Low Functional Capacity and Malnutrition
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05999370 |
Recruitment Status :
Recruiting
First Posted : August 21, 2023
Last Update Posted : August 21, 2023
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Prehabilitation Malnutrition Physical Functional Performance | Behavioral: Nutrition Behavioral: Exercise | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 60 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single (Outcomes Assessor) |
Primary Purpose: | Treatment |
Official Title: | Is Correction of Malnutrition Sufficient to Improve Low Physical Function Before Elective Colorectal Cancer Surgery? A Randomized Controlled Trial of Nutrition vs Nutrition and Exercise Prehabilitation |
Actual Study Start Date : | January 31, 2022 |
Estimated Primary Completion Date : | December 2025 |
Estimated Study Completion Date : | December 2025 |
Arm | Intervention/treatment |
---|---|
Nutrition and exercise
The nutrition intervention will be based on a comprehensive nutrition assessment by a dietitian at baseline, enabling individualized caloric and protein targets. The exercise intervention will be personalized based on a comprehensive assessment to include both a resistance and an aerobic component in the form of a "snack". |
Behavioral: Nutrition
The nutrition intervention will be based on needs assessed by indirect calorimetry, patient-generated subjective global assessment, and 24hr recall conducted at baseline, enabling individualized caloric and protein targets. Deficits in nutrient intake will be addressed with one-on-one dietary counselling and supplementation at baseline in a quantity that matches the estimated deficit in intake. Adherence will be monitored using 24-hr recalls and weight status by the dietitian weekly. Behavioral: Exercise The exercise intervention will include both a resistance and an aerobic component to be performed a total of 5 times a day, 5 times per week, 5 minutes each session, totaling 125 minutes per week. The ability to perform exercises as prescribed will be monitored with a weekly in-person or virtual supervised session. |
Nutrition only
The nutrition intervention will be based on a comprehensive nutrition assessment by a dietitian at baseline, enabling individualized caloric and protein targets.
|
Behavioral: Nutrition
The nutrition intervention will be based on needs assessed by indirect calorimetry, patient-generated subjective global assessment, and 24hr recall conducted at baseline, enabling individualized caloric and protein targets. Deficits in nutrient intake will be addressed with one-on-one dietary counselling and supplementation at baseline in a quantity that matches the estimated deficit in intake. Adherence will be monitored using 24-hr recalls and weight status by the dietitian weekly. |
- Preoperative six-minute walking distance [ Time Frame: from date of baseline assessment until date of surgery, an average of 4 weeks, recorded in meters ]Physical function will be measured with the six-minute walking test (6MWT). Patients will be instructed to walk back and forth along a 20m hallway, and the distance covered in 6 minutes (6MWD) will be recorded (meters).
- Adherence to the exercise intervention [ Time Frame: from date of baseline assessment until date of surgery,an average of 4 weeks, recorded in steps ]Adherence will be monitored by use of logbooks and a smart watch (FitBit), which records daily steps.
- Adherence to the nutrition intervention [ Time Frame: from date of baseline assessment until date of surgery, an average of 4 weeks, recorded in % of prescription adherence ]Adherence to dietary targets (energy intake) will be carefully monitored by weekly in-person or virtual visit using 24hr recalls and supplement counts (energy consumption as compared to prescribed energy targets)
- Adherence to the nutrition intervention [ Time Frame: from date of baseline assessment until date of surgery, an average of 4 weeks, recorded in % of prescription adherence ]Adherence to dietary targets (protein intake) will be carefully monitored by weekly in-person or virtual visit using 24hr recalls and supplement counts (protein consumption as compared to prescribed protein targets)
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 65 Years and older (Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Patients aged 65 years and older;
- Patients with cancer scheduled for primary colorectal resection;
- Patients with 6MWD at baseline less than 400 m;
- Patients with Patient-Generated Subjective-Global Assessment (malnutrition assessment) score equal or greater than 9.
Exclusion Criteria:
- Patients with history of premorbid conditions that contraindicate exercise including dementia, -Parkinson's disease or previous stroke with paresis;
- Metastatic cancer;
- Patients who do not speak English or French and cannot be accompanied by someone who speaks English or French;
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05999370
Contact: Chelsia Gillis, RD PhD | 514-398-7905 | chelsia.gillis@mcgill.ca | |
Contact: Natalia Tomborelli Bellafronte, RD PhD | natbella@ymail.com |
Canada, Quebec | |
MUHC Research Ethics Board | Recruiting |
Montréal, Quebec, Canada, H4A 3T2 | |
Contact: Elizabeth Craven, PhD 514 934-1934 ext 22319 reb.ct1@muhc.mcgill.ca |
Principal Investigator: | Chelsia Gillis, RD PhD | McGill University |
Responsible Party: | Chelsia Ann Gillis, Assistant Professor, McGill University |
ClinicalTrials.gov Identifier: | NCT05999370 |
Other Study ID Numbers: |
37-2021-6990 |
First Posted: | August 21, 2023 Key Record Dates |
Last Update Posted: | August 21, 2023 |
Last Verified: | August 2023 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Malnutrition Nutrition Disorders |